The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
STEC-HUS, atypical HUS and TTP are all diseases of complement activation
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
Tarr, P. I., Gordon, C. A., & Chandler, W. L. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71144-2 · Cited by 1,774
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
Tsai, H.-M., & Lian, E. C.-Y. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811263392203 · Cited by 1,760
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
Levy, G. G., Nichols, W. C., Lian, E. C., Foroud, T., McClintick, J. N., McGee, B. M., Yang, A. Y., Siemieniak, D. R., Stark, K. R., Gruppo, R., et al. (2001) · Nature · doi:10.1038/35097008 · Cited by 1,749
Furlan, M., Robles, R., Galbusera, M., Remuzzi, G., Kyrle, P. A., Brenner, B., Krause, M., Scharrer, I., Aumann, V., Mittler, U., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811263392202 · Cited by 1,657
Self-citationKarmali, M. A., Petric, M., Lim, C., Fleming, P. C., Arbus, G. S., & Lior, H. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/151.5.775 · Cited by 1,388
Atypical Hemolytic–Uremic Syndrome
Noris, M., & Remuzzi, G. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0902814 · Cited by 1,338
Self-citationEpidemic Profile of Shiga-Toxin–Producing Escherichia coli O104:H4 Outbreak in Germany
Frank, C., Werber, D., Cramer, J. P., Askar, M., Faber, M., an der Heiden, M., Bernard, H., Fruth, A., Prager, R., Spode, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106483 · Cited by 1,139
Noris, M., Caprioli, J., Bresin, E., Mossali, C., Pianetti, G., Gamba, S., Daina, E., Fenili, C., Castelletti, F., Sorosina, A., et al. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02210310 · Cited by 1,042
Self-citationGeneration of C5a in the absence of C3: a new complement activation pathway
Huber-Lang, M., Sarma, J. V., Zetoune, F. S., Rittirsch, D., Neff, T. A., McGuire, S. R., Lambris, J. D., Warner, R. L., Flierl, M. A., Hoesel, L. M., et al. (2006) · Nature Medicine · doi:10.1038/nm1419 · Cited by 975
Sarma, J. V., & Ward, P. A. (2011) · Cell and Tissue Research · doi:10.1007/s00441-010-1034-0 · Cited by 974
Origins of the E. coli Strain Causing an Outbreak of Hemolytic–Uremic Syndrome in Germany
Rasko, D. A., Webster, D. R., Sahl, J. W., Bashir, A., Boisen, N., Scheutz, F., Paxinos, E. E., Sebra, R., Chin, C.-S., Iliopoulos, D., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106920 · Cited by 823
Caprioli, J., Noris, M., Brioschi, S., Pianetti, G., Castelletti, F., Bettinaglio, P., Mele, C., Bresin, E., Cassis, L., Gamba, S., et al. (2006) · Blood · doi:10.1182/blood-2005-10-007252 · Cited by 732
Self-citationThe role of the anaphylatoxins in health and disease
Klos, A., Tenner, A. J., Johswich, K.-O., Ager, R. R., Reis, E. S., & Köhl, J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.027 · Cited by 730
Molecular Intercommunication between the Complement and Coagulation Systems
Amara, U., Flierl, M. A., Rittirsch, D., Klos, A., Chen, H., Acker, B., Brückner, U. B., Nilsson, B., Gebhard, F., Lambris, J. D., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903678 · Cited by 720
Vesely, S. K., George, J. N., Lämmle, B., Studt, J.-D., Alberio, L., El-Harake, M. A., & Raskob, G. E. (2003) · Blood · doi:10.1182/blood-2003-01-0193 · Cited by 676
Sims, P. J., Faioni, E. M., Wiedmer, T., & Shattil, S. J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81346-7 · Cited by 673
Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura
Sadler, J. E. (2008) · Blood · doi:10.1182/blood-2008-02-078170 · Cited by 574
Thrombomodulin Mutations in Atypical Hemolytic–Uremic Syndrome
Delvaeye, M., Noris, M., De Vriese, A., Esmon, C. T., Esmon, N. L., Ferrell, G., Del-Favero, J., Plaisance, S., Claes, B., Lambrechts, D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810739 · Cited by 554
Self-citationShiga toxins — from cell biology to biomedical applications
Johannes, L., & Römer, W. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2279 · Cited by 509
Anti–Factor H Autoantibodies Associated with Atypical Hemolytic Uremic Syndrome
Dragon-Durey, M.-A. G. A., Loirat, C., Cloarec, S., Macher, M.-A., Blouin, J., Nivet, H., Weiss, L., Fridman, W. H., & Frémeaux-Bacchi, V. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004050380 · Cited by 502
Genetic studies into inherited and sporadic hemolytic uremic syndrome
Warwicker, P., Goodship, T. H. J., Donne, R. L., Pirson, Y., Nicholls, A., Ward, R. M., Turnpenny, P., & Goodship, J. A. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00824.x · Cited by 497
Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura
Ruggenenti, P., Noris, M., & Remuzzi, G. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.060003831.x · Cited by 489
Self-citationMutations in Complement Factor I Predispose to Development of Atypical Hemolytic Uremic Syndrome
Kavanagh, D., Kemp, E. J., Mayland, E., Winney, R. J., Duffield, J. S., Warwick, G., Richards, A., Ward, R., Goodship, J. A., & Goodship, T. H. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010103 · Cited by 475
Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene Mutations
Fakhouri, F., Roumenina, L., Provot, F., Sallée, M., Caillard, S., Couzi, L., Essig, M., Ribes, D., Dragon-Durey, M.-A., Bridoux, F., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009070706 · Cited by 467
de Jorge, E. G., Harris, C. L., Esparza-Gordillo, J., Carreras, L., Arranz, E. A., Garrido, C. A., López-Trascasa, M., Sánchez-Corral, P., Morgan, B. P., & de Córdoba, S. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603420103 · Cited by 447
Eculizumab in Severe Shiga-Toxin–Associated HUS
Lapeyraque, A.-L., Malina, M., Fremeaux-Bacchi, V., Boppel, T., Kirschfink, M., Oualha, M., Proulx, F., Clermont, M.-J., Le Deist, F., Niaudet, P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1100859 · Cited by 423
Richards, A., Kemp, E. J., Liszewski, M. K., Goodship, J. A., Lampe, A. K., Decorte, R., Müslümanogğlu, M. H., Kavukcu, S., Filler, G., Pirson, Y., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135497100 · Cited by 405
Platelet activation leads to activation and propagation of the complement system
del Conde, I., Crúz, M. A., Zhang, H., López, J. A., & Afshar-Kharghan, V. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041497 · Cited by 397
Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome
Frémeaux-Bacchi, V., Miller, E. C., Liszewski, M. K., Strain, L., Blouin, J., Brown, A. L., Moghal, N., Kaplan, B. S., Weiss, R. A., Lhotta, K., et al. (2008) · Blood · doi:10.1182/blood-2008-01-133702 · Cited by 372
Risitano, A. M., Notaro, R., Marando, L., Serio, B., Ranaldi, D., Seneca, E., Ricci, P., Alfinito, F., Camera, A., Gianfaldoni, G., et al. (2009) · Blood · doi:10.1182/blood-2008-11-189944 · Cited by 361
Moore, I., Strain, L., Pappworth, I., Kavanagh, D., Barlow, P. N., Herbert, A. P., Schmidt, C. Q., Staniforth, S. J., Holmes, L. V., Ward, R., et al. (2010) · Blood · doi:10.1182/blood-2009-05-221549 · Cited by 357
Manuelian, T., Hellwage, J., Meri, S., Caprioli, J., Noris, M., Heinen, S., Jozsi, M., Neumann, H. P. H., Remuzzi, G., & Zipfel, P. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16651 · Cited by 350
Self-citationEculizumab for Atypical Hemolytic–Uremic Syndrome
Nürnberger, J., Philipp, T., Witzke, O., Saez, A. O., Vester, U., Baba, H. A., Kribben, A., Zimmerhackl, L. B., Janecke, A. R., Nagel, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0808527 · Cited by 346
Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome
Fremeaux-Bacchi, V, Dragon-Durey, M.-A., Blouin, J., Vigneau, C., Kuypers, D., Boudailliez, B., Loirat, C., Rondeau, E., & Fridman, W. H. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.019083 · Cited by 339
Tedesco, F., Pausa, M., Nardon, E., Introna, M., Mantovani, A., & Dobrina, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1619 · Cited by 318
Richards, A., Buddles, M. R., Donne, R. L., Kaplan, B. S., Kirk, E., Venning, M. C., Tielemans, C. L., Goodship, J. A., & Goodship, T. H. J. (2001) · The American Journal of Human Genetics · doi:10.1086/318203 · Cited by 310
Endothelial heterogeneity in Shiga toxin receptors and responses
Obrig, T. G., Louise, C. B., Lingwood, C. A., Boyd, B., Barley-Maloney, L., & Daniel, T. O. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82282-7 · Cited by 295
Inhibiting the C5–C5a receptor axis
Woodruff, T. M., Nandakumar, K. S., & Tedesco, F. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.04.014 · Cited by 289
Salmon, J. E., Heuser, C., Triebwasser, M., Liszewski, M. K., Kavanagh, D., Roumenina, L., Branch, D. W., Goodship, T., Fremeaux-Bacchi, V., & Atkinson, J. P. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001013 · Cited by 285
Esparza-Gordillo, J., Jorge, E. G. D., Buil, A., Berges, L. C., López-Trascasa, M., Sánchez-Corral, P., & Córdoba, S. R. D. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi066 · Cited by 281
Pickering, M. C., de Jorge, E. G., Martinez-Barricarte, R., Recalde, S., Garcia-Layana, A., Rose, K. L., Moss, J., Walport, M. J., Cook, H. T., de Córdoba, S. R., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070301 · Cited by 278
Eculizumab for Congenital Atypical Hemolytic–Uremic Syndrome
Gruppo, R. A., & Rother, R. P. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0809959 · Cited by 275
Platt, J. L., Vercellotti, G. M., Lindman, B. J., Oegema, T. R., Bach, F. H., & Dalmasso, A. P. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.4.1363 · Cited by 273
C5a Induces Tissue Factor Activity on Endothelial Cells
Ikeda, K., Nagasawa, K., Horiuchi, T., Tsuru, T., Nishizaka, H., & Niho, Y. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1655974 · Cited by 272
Complement activation on platelets: Implications for vascular inflammation and thrombosis
Peerschke, E. I., Yin, W., & Ghebrehiwet, B. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.05.009 · Cited by 251
Pathophysiology of thrombotic thrombocytopenic purpura
Tsai, H.-M. (2010) · International Journal of Hematology · doi:10.1007/s12185-009-0476-1 · Cited by 245
Complement alternative pathway acts as a positive feedback amplification of neutrophil activation
Camous, L., Roumenina, L., Bigot, S., Brachemi, S., Frémeaux-Bacchi, V., Lesavre, P., & Halbwachs-Mecarelli, L. (2011) · Blood · doi:10.1182/blood-2010-05-283564 · Cited by 244
Morigi, M., Galbusera, M., Gastoldi, S., Locatelli, M., Buelli, S., Pezzotta, A., Pagani, C., Noris, M., Gobbi, M., Stravalaci, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100491 · Cited by 235
Self-citationJózsi, M., Strobel, S., Dahse, H.-M., Liu, W.-S., Hoyer, P. F., Oppermann, M., Skerka, C., & Zipfel, P. F. (2007) · Blood · doi:10.1182/blood-2007-02-071472 · Cited by 233
Verhoef, G., Johnsen, H. E., Rossi, F. G., Salar, A., Hamilton, L., Schoonen, W. M., Pujol, B., & Duhrsen, U. (2008) · Blood · doi:10.1182/blood.v112.11.4948.4948 · Cited by 233
Fremeaux-Bacchi, V. A. A., Moulton, E. A., Kavanagh, D., Dragon-Durey, M.-A. G. A., Blouin, J., Caudy, A., Arzouk, N., Cleper, R., Francois, M., Guest, G., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005101051 · Cited by 229
Transient perturbation of endothelial integrity induced by natural antibodies and complement.
Saadi, S., & Platt, J. L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.21 · Cited by 224
van Setten, P., Monnens, L., Verstraten, R., van den Heuvel, L., & van Hinsbergh, V. (1996) · Blood · doi:10.1182/blood.v88.1.174.174 · Cited by 223
Orth, D., Khan, A. B., Naim, A., Grif, K., Brockmeyer, J., Karch, H., Joannidis, M., Clark, S. J., Day, A. J., Fidanzi, S., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900151 · Cited by 209
Neumann, H. P. H., Salzmann, M., Bohnert-Iwan, B., Mannuelian, T., Skerka, C., Lenk, D., Bender, B. U., Cybulla, M., Riegler, P., Königsrainer, A., et al. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.9.676 · Cited by 206
Human platelet activation by C3a and C3a des-arg.
Polley, M. J., & Nachman, R. L. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.2.603 · Cited by 206
Complement Mutation-Associated De Novo Thrombotic Microangiopathy Following Kidney Transplantation
Le Quintrec, M., Lionet, A., Kamar, N., Karras, A., Barbier, S., Buchler, M., Fakhouri, F., Provost, F., Fridman, W. H., Thervet, E., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02297.x · Cited by 203
Alternative Pathway of Complement in Children with Diarrhea-Associated Hemolytic Uremic Syndrome
Thurman, J. M., Marians, R., Emlen, W., Wood, S., Smith, C., Akana, H., Holers, V. M., Lesser, M., Kline, M., Hoffman, C., et al. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02730409 · Cited by 203
Ståhl, A.-L., Sartz, L., & Karpman, D. (2011) · Blood · doi:10.1182/blood-2010-09-309161 · Cited by 198
Bienaime, F., Dragon-Durey, M.-A., Regnier, C. H., Nilsson, S. C., Kwan, W. H., Blouin, J., Jablonski, M., Renault, N., Rameix-Welti, M.-A., Loirat, C., et al. (2010) · Kidney International · doi:10.1038/ki.2009.472 · Cited by 192
C5a-Induced Gene Expression in Human Umbilical Vein Endothelial Cells
Albrecht, E. A., Chinnaiyan, A. M., Varambally, S., Kumar-Sinha, C., Barrette, T. R., Sarma, J. V., & Ward, P. A. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63173-2 · Cited by 178
Ferreira, V. P., Herbert, A. P., Cortés, C., McKee, K. A., Blaum, B. S., Esswein, S. T., Uhrín, D., Barlow, P. N., Pangburn, M. K., & Kavanagh, D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804031 · Cited by 173
Vergunst, C. E., Gerlag, D. M., Dinant, H., Schulz, L., Vinkenoog, M., Smeets, T. J. M., Sanders, M. E., Reedquist, K. A., & Tak, P. P. (2007) · Rheumatology · doi:10.1093/rheumatology/kem222 · Cited by 163
Eculizumab and Renal Transplantation in a Patient with CAPS
Lonze, B. E., Singer, A. L., & Montgomery, R. A. (2010) · New England Journal of Medicine · doi:10.1056/nejmc0910965 · Cited by 162
Roumenina, L. T., Jablonski, M., Hue, C., et al. (2009) · Blood · doi:10.1182/blood-2009-01-197640 · Cited by 157
Genetics and complement in atypical HUS
Kavanagh, D., & Goodship, T. H. J. (2010) · Pediatric Nephrology · doi:10.1007/s00467-010-1555-5 · Cited by 153
Mutations in complement C3 predispose to development of atypical haemolytic uraemic syndrome
Frémeaux‐Bacchi, V., Goodship, T. H. J., Régnier, C. H., Dragon‐Durey, M., Janssen, B. J. C., & Atkinson, J. P. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.06.038 · Cited by 153
Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome
Kavanagh, D., Richards, A., Noris, M., Hauhart, R. E., Liszewski, M. K., Karpman, D., Goodship, J. A., Frémeaux‐Bacchi, V., Remuzzi, G., Goodship, T. H. J., et al. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.05.004 · Cited by 152
Self-citationFang, C. J., Frémeaux‐Bacchi, V., Liszewski, M. K., Pianetti, G., Noris, M., Goodship, T. H. J., & Atkinson, J. P. (2007) · Blood · doi:10.1182/blood-2007-04-084533 · Cited by 148
Self-citationStåhl, A.-L., Vaziri‐Sani, F., Heinen, S., Kristoffersson, A., GYDELL, K., Raafat, R. H., Gutiérrez, A., Beringer, O., Zipfel, P. F., & Karpman, D. (2008) · Blood · doi:10.1182/blood-2007-08-106153 · Cited by 139
Complement activation in thrombotic thrombocytopenic purpura
RÉTI, M., FARKAS, P., CSUKA, D., RÁZSÓ, K., SCHLAMMADINGER, Á., UDVARDY, M. L., MADÁCH, K., DOMJÁN, G., BERECZKI, C., REUSZ, G. S., et al. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04674.x · Cited by 138
Karpman, D., Papadopoulou, D. N., Nilsson, K., Sjögren, A.-C., Mikaelsson, C. G., & Lethagen, S. (2001) · Blood · doi:10.1182/blood.v97.10.3100 · Cited by 135
Esparza-Gordillo, J., de Jorge, E. G., Abarrategui-Garrido, C., CARRERAS, L., López‐Trascasa, M., Sánchez‐Corral, P., & de Córdoba, S. R. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2005.11.008 · Cited by 131
Letter: Allergy, immunodeficiency, and epilepsy.
As, C. (1975) · PubMed · Cited by 124
Zoja, C., Angioletti, S., Donadelli, R., Zanchi, C., Tomasoni, S., Binda, E., Imberti, B., Loo, D. M. W. M. T., Monnens, L. A. H., Remuzzi, G., et al. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00503.x · Cited by 120
Self-citationThe human complement system in thrombin-mediated platelet function.
Polley, M. J., & Nachman, R. L. (1978) · The Journal of Experimental Medicine · doi:10.1084/jem.147.6.1713 · Cited by 108
Botto, M., Lissandrini, D., Sorio, C., & Walport, M. J. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.4.1348 · Cited by 106
Morigi, M., Galbusera, M., Binda, E., Imberti, B., Gastoldi, S., Remuzzi, A., Zoja, C., & Remuzzi, G. (2001) · Blood · doi:10.1182/blood.v98.6.1828 · Cited by 102
Self-citationEculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura
Chapin, J. C., Weksler, B. B., MAGRO, C. M. J., & Laurence, J. C. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09084.x · Cited by 100
Petruzziello-Pellegrini, T. N., Yuen, D. A., Page, A. V., Patel, S., Soltyk, A. M., Matouk, C. C., Wong, D. K., Turgeon, P. J., Fish, J. E., Ho, J. J. D., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci57313 · Cited by 98
Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome
Vaziri‐Sani, F., Holmberg, L., Sjöholm, A. G., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5000155 · Cited by 88
Pexelizumab in ischemic heart disease: A systematic review and meta-analysis on 15,196 patients
Testa, L., van Gaal, W. J., Bhindi, R., Biondi‐Zoccai, G., Abbate, A., Agostoni, P., Porto, I., Andreotti, F., Crea, F., & BANNING, A. P. (2008) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2007.12.062 · Cited by 87
Familial hemolytic uremic syndrome associated with complement factor H deficiency
Landau, D., Shalev, H., Levy-Finer, G., et al. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.112649 · Cited by 85
Ruiz‐Torres, M. P., Casiraghi, F., Galbusera, M., Macconi, D., Gastoldi, S., Todeschini, M., Porrati, F., Belotti, D., Pogliani, E., Remuzzi, G., et al. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-07-0450 · Cited by 83
Self-citationDobrina, A., Pausa, M., Fabio Fischetti, I., Bulla, R., Vecile, E., Ferrero, E., Mantovani, A., & Tedesco, F. (2002) · Blood · doi:10.1182/blood.v99.1.185 · Cited by 82
Lazar, H. L., Bokesch, P. M., van Lenta, F., Fitzgerald, C. A., Emmett, C., Marsh, H. C., Ryan, U. S., & OBE and the TP10 Cardiac Surgery Study Group (2004) · Circulation · doi:10.1161/01.cir.0000138315.99788.eb · Cited by 76
Niculescu, F. I., & Rus, H. (2001) · Immunologic Research · doi:10.1385/ir:24:2:191 · Cited by 70
Vogt, W. (1996) · Immunobiology · doi:10.1016/s0171-2985(96)80050-7 · Cited by 69
Høgåsen, A. K. M., Würzner, R., Abrahamsen, T. G., & Dierich, M. P. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4734 · Cited by 66
Abnormal platelet function in C3-deficient mice
Gushiken, F. C., HAN, H., Li, J., Rumbaut, R. E., & Afshar‐Kharghan, V. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03334.x · Cited by 63
Therapeutic targeting of the complement system in age‐related macular degeneration: a review
Troutbeck, R., Al‐Qureshi, S., & Guymer, R. H. (2012) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2011.02581.x · Cited by 60
Heinen, S., Józsi, M., Hartmann, A., Noris, M., Remuzzi, G., Skerka, C., & Zipfel, P. F. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006091069 · Cited by 59
Self-citationKilgore, K. S., Ward, P. A., & Warren, J. S. (1998) · Inflammation · doi:10.1023/a:1022362413939 · Cited by 57
Nestoridi, E., Tsukurov, O. I., Kushak, R. I., Ingelfinger, J. R., & Grabowski, E. F. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01205.x · Cited by 39
Genetics and Genetic Testing in Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic Purpura
Noris, M., & Remuzzi, G. (2010) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2010.06.006 · Cited by 34
Self-citationWright, Wang, Hornstein, et al. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01751.x · Cited by 27
INF2 Is Another Piece of the Jigsaw Puzzle for FSGS
Pei, Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121293 · Cited by 14
Cited by
Padmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
Overview of complement activation and regulation
Noris, M., & Remuzzi, G. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.08.001 · Cited by 864
Self-citationThe immune system and kidney disease: basic concepts and clinical implications
Kurts, C., Panzer, U., Anders, H.-J., & Rees, A. J. (2013) · Nature Reviews Immunology · doi:10.1038/nri3523 · Cited by 696
Complement in disease: a defence system turning offensive
Ricklin, D., Reis, E. S., & Lambris, J. D. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.70 · Cited by 550
Endothelium structure and function in kidney health and disease
Jourde-Chiche, N., Fakhouri, F., Dou, L., Bellien, J., Burtey, S., Frimat, M., Jarrot, P.-A., Kaplanski, G., Le Quintrec, M., Pernin, V., et al. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0098-z · Cited by 493
Metadata
- Authors
- Noris, M., Mescia, F., & Remuzzi, G.
- Venue
- Nature Reviews Nephrology
- Published
- 2012-09-18
- Volume
- 8
- Issue
- 11
- Pages
- 622-633
- ISSN
- 1745-8323 (ISSN-L)
- 1759-5061
- 1759-507X
- OpenAlex
- W2038181025
- Cited by
- 383
- References
- 98
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.